David Sheehan

Founder, President and CEO at Nucleus Biologics

Speaker

David Sheehan is the Founder, President, and CEO of Nucleus Biologics and Stoic Bio. Dave started the company with a simple goal: create and commercialize industry-first tools to allow therapy developers to own and optimize their media or buffer as a critical drug input. Nucleus Biologics is the leading custom media and buffer company for cell and gene therapy and offers NB-Lux™, a digital platform for media and buffer ordering, and NB-AIR™, an AI platform that recommends components for your media based on desired Critical Quality Attributes. Stoic Bio commercialized the first pod-based, point-of-use benchtop media and buffer mixing system, named Krakatoa™, that is now moving to bioreactor scale. Prior to Nucleus Biologics, Dave was COO of Volcano Corporation, a publicly held life sciences company that was sold to Philips for $1.2 billion. Previous to Volcano, Dave was the CEO or in leadership positions at various companies including Baxter and Haemonetics. Dave holds an MBA from The Tuck School at Dartmouth College and a BS in Mechanical Engineering from Worcester Polytechnic Institute.